FDA-Approved Morning Sickness Drug Now Available
Duchesnay USA announced the availability of Diclegis (doxylamine succinate and pyridoxine HCl) delayed-release tablets nationwide. Diclegis is approved as the only treatment for nausea and vomiting of pregnancy in women who do not respond to conservative management.
Diclegis contains 10mg of doxylamine succinate, an antihistamine, and 10mg pyridoxine HCl, a vitamin B6 analog. The exact mechanism of Diclegis in treating “morning sickness” is unknown.
Diclegis delayed-release tablets are available in 100-count bottles.
For more information call (855) 722-7734 or visit Diclegis.com.